Home/Filings/4/0001127602-24-026385
4//SEC Filing

Grogan Jane 4

Accession 0001127602-24-026385

CIK 0000875045other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:39 PM ET

Size

8.2 KB

Accession

0001127602-24-026385

Insider Transaction Report

Form 4
Period: 2024-11-01
Grogan Jane
Head of Research
Transactions
  • Tax Payment

    Common Stock

    2024-11-01$173.79/sh204$35,453491 total
  • Exercise/Conversion

    Common Stock

    2024-11-01+695695 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-11-016951,390 total
    Exercise: $0.00Exp: 2026-11-01Common Stock (695 underlying)
Footnotes (1)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of November 1, 2023.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001995547

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:39 PM ET
Size
8.2 KB